BR9711414A - Processo e composições farmacêuticas para abaixamento do nìvel de ácido úrico no organismo humano e para profilaxia da gota, hiperuricemia ou doença cardìaca coronária em humanos, e, uso de um composto - Google Patents
Processo e composições farmacêuticas para abaixamento do nìvel de ácido úrico no organismo humano e para profilaxia da gota, hiperuricemia ou doença cardìaca coronária em humanos, e, uso de um compostoInfo
- Publication number
- BR9711414A BR9711414A BR9711414-6A BR9711414A BR9711414A BR 9711414 A BR9711414 A BR 9711414A BR 9711414 A BR9711414 A BR 9711414A BR 9711414 A BR9711414 A BR 9711414A
- Authority
- BR
- Brazil
- Prior art keywords
- humans
- hyperuricemia
- compound
- level
- heart disease
- Prior art date
Links
- 201000001431 Hyperuricemia Diseases 0.000 title abstract 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title abstract 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000029078 coronary artery disease Diseases 0.000 title abstract 3
- 229940116269 uric acid Drugs 0.000 title abstract 3
- 201000005569 Gout Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
"PROCESSOS E COMPOSIçõES FARMACêUTICAS PARA ABAIXAMENTO DO NìVEL DE áCIDO úRICO NO ORGANISMO HUMANO E PARA PROFILAXIA DA GOTA, HIPERURICEMIA OU DOENçA CARDìACA CORONáRIA EM HUMANOS, E, USO DE UM COMPOSTO". Um composto de fórmula (I) ou um seu sal farmaceuticamente aceitável, em que R~ 1~ e R~ 2~ são independentemente H ou metila (por exemplo, cloridreto de N,N-dimetil-1-[1-(4-clorofenil)ciclobutil]-3-mentilbutil amina, opcionalmente na forma de seu monoidrato) é usado para abaixar o nível de ácido úrico em humanos, por exemplo, em humanos sofrendo de ou sob risco de desnvolver gota, hiperuricemia ou doença cardíaca coronária.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619962.5A GB9619962D0 (en) | 1996-09-25 | 1996-09-25 | Medical treatment |
| PCT/EP1997/005034 WO1998013033A1 (en) | 1996-09-25 | 1997-09-15 | Medical treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9711414A true BR9711414A (pt) | 2000-04-25 |
Family
ID=10800448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9711414-6A BR9711414A (pt) | 1996-09-25 | 1997-09-15 | Processo e composições farmacêuticas para abaixamento do nìvel de ácido úrico no organismo humano e para profilaxia da gota, hiperuricemia ou doença cardìaca coronária em humanos, e, uso de um composto |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6162831A (pt) |
| EP (1) | EP1007023B1 (pt) |
| JP (1) | JP2001501608A (pt) |
| KR (1) | KR20000048568A (pt) |
| CN (1) | CN1231604A (pt) |
| AT (1) | ATE239460T1 (pt) |
| AU (1) | AU722129B2 (pt) |
| BG (1) | BG103278A (pt) |
| BR (1) | BR9711414A (pt) |
| CA (1) | CA2266438A1 (pt) |
| DE (1) | DE69721838T2 (pt) |
| DK (1) | DK1007023T3 (pt) |
| ES (1) | ES2199374T3 (pt) |
| GB (1) | GB9619962D0 (pt) |
| HR (1) | HRP970519A2 (pt) |
| HU (1) | HUP9904545A3 (pt) |
| IL (1) | IL128851A (pt) |
| NO (1) | NO991425D0 (pt) |
| NZ (1) | NZ334668A (pt) |
| PL (1) | PL332423A1 (pt) |
| PT (1) | PT1007023E (pt) |
| SK (1) | SK32199A3 (pt) |
| TR (1) | TR199900649T2 (pt) |
| TW (1) | TW415842B (pt) |
| WO (1) | WO1998013033A1 (pt) |
| ZA (1) | ZA978573B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
| US6331571B1 (en) | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
| US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
| US6339106B1 (en) | 1999-08-11 | 2002-01-15 | Sepracor, Inc. | Methods and compositions for the treatment and prevention of sexual dysfunction |
| PL365463A1 (en) * | 1999-03-19 | 2005-01-10 | Knoll Gmbh | Treatment of osteoarthritis |
| US6552087B1 (en) | 1999-03-19 | 2003-04-22 | Abbott Gmbh & Co. Kg | Therapeutic agent comprising (+)-sibutramine |
| US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| US6610887B2 (en) | 2001-04-13 | 2003-08-26 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
| US9655932B2 (en) * | 2002-03-13 | 2017-05-23 | Kibow Biotech, Inc. | Composition and method for preventing or treating gout or hyperuricemia |
| US11103542B2 (en) | 2002-03-13 | 2021-08-31 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
| MXPA05003355A (es) * | 2002-10-05 | 2005-10-18 | Hanmi Pharm Ind Co Ltd | Composicion farmaceutica que comprende semihidrato de metansulfonato de sibutramina cristalino. |
| US20050131074A1 (en) * | 2003-08-04 | 2005-06-16 | Beckman Kristen M. | Methods for treating metabolic syndrome |
| WO2006012438A2 (en) * | 2004-07-21 | 2006-02-02 | University Of Florida Research Foundation, Inc. | Compositions and methods for treatment and prevention of insulin resistance |
| KR100627687B1 (ko) * | 2005-04-20 | 2006-09-25 | 주식회사 씨티씨바이오 | 시부트라민 유리염기 함유 조성물 및 이의 제조방법 |
| BRPI0716002A2 (pt) * | 2006-11-22 | 2013-07-30 | Sk Chemicals Co Ltd | complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade |
| WO2018125735A1 (en) | 2016-12-29 | 2018-07-05 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
| CA3118311A1 (en) * | 2018-11-02 | 2020-05-07 | Ampersand Biopharmaceuticals, Inc. | Management of risk of cation overload and electrolyte imbalance with topically applied buffers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52768B1 (en) * | 1981-04-06 | 1988-02-17 | Boots Co Ltd | 1-arylcyclobutylalkylamine compounds useful as therapeutic agents |
| GB8531071D0 (en) * | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
| GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
| JP2675573B2 (ja) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | 脳機能改善剤 |
| IE61928B1 (en) * | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
| JPH07508281A (ja) * | 1992-06-23 | 1995-09-14 | セプラコア インコーポレーテッド | 光学的に純粋な（＋）シブトラミンを用いるうつ病およびその他の障害を治療する方法ならびに組成物 |
| WO1994000114A1 (en) * | 1992-06-23 | 1994-01-06 | Sepracor Inc. | Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine |
| US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
-
1996
- 1996-09-25 GB GBGB9619962.5A patent/GB9619962D0/en active Pending
-
1997
- 1997-09-15 KR KR1019990702491A patent/KR20000048568A/ko not_active Ceased
- 1997-09-15 PL PL97332423A patent/PL332423A1/xx unknown
- 1997-09-15 BR BR9711414-6A patent/BR9711414A/pt not_active Application Discontinuation
- 1997-09-15 CA CA002266438A patent/CA2266438A1/en not_active Abandoned
- 1997-09-15 TR TR1999/00649T patent/TR199900649T2/xx unknown
- 1997-09-15 AT AT97942030T patent/ATE239460T1/de not_active IP Right Cessation
- 1997-09-15 JP JP10515217A patent/JP2001501608A/ja active Pending
- 1997-09-15 CN CN97198232A patent/CN1231604A/zh active Pending
- 1997-09-15 US US09/269,339 patent/US6162831A/en not_active Expired - Fee Related
- 1997-09-15 DE DE69721838T patent/DE69721838T2/de not_active Expired - Fee Related
- 1997-09-15 IL IL12885197A patent/IL128851A/xx not_active IP Right Cessation
- 1997-09-15 SK SK321-99A patent/SK32199A3/sk unknown
- 1997-09-15 HU HU9904545A patent/HUP9904545A3/hu unknown
- 1997-09-15 ES ES97942030T patent/ES2199374T3/es not_active Expired - Lifetime
- 1997-09-15 NZ NZ334668A patent/NZ334668A/xx unknown
- 1997-09-15 DK DK97942030T patent/DK1007023T3/da active
- 1997-09-15 AU AU43851/97A patent/AU722129B2/en not_active Ceased
- 1997-09-15 PT PT97942030T patent/PT1007023E/pt unknown
- 1997-09-15 EP EP97942030A patent/EP1007023B1/en not_active Expired - Lifetime
- 1997-09-15 WO PCT/EP1997/005034 patent/WO1998013033A1/en not_active Ceased
- 1997-09-25 ZA ZA978573A patent/ZA978573B/xx unknown
- 1997-09-25 HR HR9619962.5A patent/HRP970519A2/hr not_active Application Discontinuation
- 1997-09-25 TW TW086113992A patent/TW415842B/zh not_active IP Right Cessation
-
1999
- 1999-03-24 NO NO991425A patent/NO991425D0/no unknown
- 1999-03-24 BG BG103278A patent/BG103278A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69721838T2 (de) | 2004-01-22 |
| KR20000048568A (ko) | 2000-07-25 |
| HRP970519A2 (en) | 1998-08-31 |
| DK1007023T3 (da) | 2003-08-25 |
| AU722129B2 (en) | 2000-07-20 |
| DE69721838D1 (de) | 2003-06-12 |
| CA2266438A1 (en) | 1998-04-02 |
| CN1231604A (zh) | 1999-10-13 |
| HUP9904545A2 (hu) | 2000-11-28 |
| NO991425L (no) | 1999-03-24 |
| IL128851A0 (en) | 2000-01-31 |
| TR199900649T2 (xx) | 1999-07-21 |
| ZA978573B (en) | 1999-03-25 |
| EP1007023A1 (en) | 2000-06-14 |
| ES2199374T3 (es) | 2004-02-16 |
| BG103278A (en) | 2000-01-31 |
| WO1998013033A1 (en) | 1998-04-02 |
| GB9619962D0 (en) | 1996-11-13 |
| PL332423A1 (en) | 1999-09-13 |
| AU4385197A (en) | 1998-04-17 |
| EP1007023B1 (en) | 2003-05-07 |
| NZ334668A (en) | 2000-07-28 |
| SK32199A3 (en) | 1999-12-10 |
| TW415842B (en) | 2000-12-21 |
| PT1007023E (pt) | 2003-08-29 |
| NO991425D0 (no) | 1999-03-24 |
| HUP9904545A3 (en) | 2000-12-28 |
| JP2001501608A (ja) | 2001-02-06 |
| US6162831A (en) | 2000-12-19 |
| ATE239460T1 (de) | 2003-05-15 |
| IL128851A (en) | 2001-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9711414A (pt) | Processo e composições farmacêuticas para abaixamento do nìvel de ácido úrico no organismo humano e para profilaxia da gota, hiperuricemia ou doença cardìaca coronária em humanos, e, uso de um composto | |
| NO306464B1 (no) | Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter | |
| FI935675A0 (fi) | Pyrazolopyrimidiner | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| BR0113039A (pt) | Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto | |
| BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
| MX9801716A (es) | Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina. | |
| BR9812492A (pt) | Composto, uso do mesmo, formulação farmacêutica, e, processos para o tratamento de uma doença cardiovascular, para o tratamento de uma vasoconstrição, e para a preparação de compostos | |
| DK555089D0 (da) | Farmaceutiske praeparater indeholdende n-(3,4-dimethoxycinnamoyl)anthranilsyre | |
| BR9807950A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto | |
| PT920865E (pt) | Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos | |
| BR0113590A (pt) | 7-oxo-piridopirimidinas | |
| DE60220055D1 (de) | 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden | |
| BR0009080A (pt) | Método de tratamento da apnéia do sono | |
| ATE40127T1 (de) | 1,5-benzothiazepinderivate, verfahren zu ihrer herstellung und arzneimittel. | |
| KR960034190A (ko) | N-아실피페라진 유도체 및 항균제, 항궤양제 | |
| BR9810214A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, para tratar ou reduzir o risco de doença inflamatória e de dor em uma pessoa sofrendo de ou sob risco de dita doença, de tratamento, e para a preparação de um composto | |
| DK520787A (da) | Terapeutisk middel indeholdende propentofyllin eller derivater deraf til brug ved behandling af peptisk ulcus | |
| GR3019970T3 (en) | Pharmaceutical compositions for use in treating aids | |
| DE19780042D2 (de) | Therapeutische Mittel, enthaltend organische Selenverbindungen gegen Asthma | |
| BR0009081A (pt) | Tratamento de osteoartrite | |
| BR0315713A (pt) | Composto, processo para a preparação do composto, composição farmacêutica, métodos para reduzir a glicose, para a prevenção ou para o tratamento de doenças e uso do composto | |
| BR0008545A (pt) | Processo para a preparação de um composto, e, composto | |
| BR0009160A (pt) | Tratamento de hérnia de hiato | |
| RU94019332A (ru) | 2-замещенные пергидро-1-h-пиридо/1,2-а/пиразины, способ их получения, фармацевтическая композиция и способ лечения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |